Log In
person
Kiniksa Pharmaceuticals International plc
KNSA
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Biopharmaceuticals |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
233.18M | 86.28% |
| Biopharmaceuticals |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
37.08M | 13.72% |
| keyboard_arrow_down |
Biopharmaceuticals
Branded Pharmaceuticals (outsourced)
|
233.18M | 86.28% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Biopharmaceuticals
Pharmaceutical Patent Licensing
|
37.08M | 13.72% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||